Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

Literature DB >> 105970

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

N A Buckell, S R Gould, D W Day, J E Lennard-Jones, A M Edwards.

Abstract

Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.

Entities: Chemical Disease Species

Mesh：

Substances：
Cromolyn Sodium

Year: 1978 PMID： 105970 PMCID： PMC1412329 DOI： 10.1136/gut.19.12.1140

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

5 in total

1. VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors: J H BARON; A M CONNELL; J E LENNARD-JONES
Journal: Br Med J Date: 1964-01-11

2. The clinical significance of seromucoids in regional ileitis and ulcerative colitis.

Authors: W T COOKE; D I FOWLER; E V COX; R GADDIE; M J MEYNELL
Journal: Gastroenterology Date: 1958-05 Impact factor: 22.682

3. The technique and interpretation of rectal biopsies in inflammatory bowel disease.

Authors: B C Morson
Journal: Pathol Annu Date: 1974

4. Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.

Authors: V Mani; G Lloyd; F H Green; H Fox; L A Turnberg
Journal: Lancet Date: 1976-02-28 Impact factor: 79.321

5. Disodium cromoglycate in the treatment of chronic proctitis.

Authors: R V Heatley; B J Calcraft; J Rhodes; E Owen; B K Evans
Journal: Gut Date: 1975-07 Impact factor: 23.059

5 in total

14 in total

Review 1. Drug therapy of ulcerative colitis.

Authors: B Crotty; D P Jewell
Journal: Br J Clin Pharmacol Date: 1992-09 Impact factor: 4.335

2. Meta-analysis of the placebo response in ulcerative colitis.

Authors: Sagar Garud; Alphonso Brown; Adam Cheifetz; Emily B Levitan; Ciaran P Kelly
Journal: Dig Dis Sci Date: 2007-10-13 Impact factor: 3.199

3. Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis.

Authors: R H Grace; A E Gent; M D Hellier
Journal: Gut Date: 1987-01 Impact factor: 23.059

4. Sodium cromoglycate in proctitis and ulcerative colitis.

Authors: R N Allan
Journal: Br Med J (Clin Res Ed) Date: 1982-01-09

5. A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.

Authors: P J Whorwell; G M Whorwell; J Bamforth; D Colin Jones; P Down; A Edwards; A E Gent; P Golding; K R Gough; M D Hellier; P Isaacson; C A Loehry; G J Milton-Thompson; C L Smith; R P Waldram; R Wright
Journal: Postgrad Med J Date: 1981-07 Impact factor: 2.401

Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.

1. VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

2. The clinical significance of seromucoids in regional ileitis and ulcerative colitis.

3. The technique and interpretation of rectal biopsies in inflammatory bowel disease.

4. Treatment of ulcerative colitis with oral disodium cromoglycate. A double-blind controlled trial.

5. Disodium cromoglycate in the treatment of chronic proctitis.

Review 1. Drug therapy of ulcerative colitis.

2. Meta-analysis of the placebo response in ulcerative colitis.

3. Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis.

4. Sodium cromoglycate in proctitis and ulcerative colitis.

5. A double-blind controlled trial of the effect of sodium cromoglycate in preventing relapse in ulcerative colitis.

Review 6. The mucosal mast cell and its role in gastrointestinal allergic diseases.

7. Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

8. Treatment of ulcerative colitis.

Review 9. Assessment of drug therapy in inflammatory bowel disease.

10. Treatment of pyoderma gangrenosum with disodium cromoglycate.